Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects - Concepedia

Concepedia

Publication | Open Access

Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects

DOI Full Paper Access

205

Citations

28

References

2013

Year

Bertrand Cariou, Rémy Hanf, S. Lambert-Porcheron, Yassine Zaïr, Valérie Sauvinet, Benoît Noël, Laurent Flet, Hubert Vidal, Bart Staels, Martine Laville

Abstract

The dual PPARα/δ agonist GFT505 is a liver-targeted insulin-sensitizer that is a promising drug candidate for the treatment of type 2 diabetes and nonalcoholic fatty liver disease.

References

	Year	Citations

Page 1